A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
Jessica D. Kessler(Baylor College of Medicine), Thomas F. Westbrook(Baylor College of Medicine), Rocío Domínguez-Vidaña(Baylor College of Medicine), Qikai Xu(Brigham and Women's Hospital), Stephen J. Elledge(Howard Hughes Medical Institute), Mitchell Rao(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine), C. Kent Osborne(Texas Oncology), Mamie Z. Li(Howard Hughes Medical Institute), Ji Luo(Central South University), Nicole L. Solimini(Brigham and Women's Hospital), Chad J. Creighton(Baylor College of Medicine), Tingting Sun(Northwest University), Ido Golding(University of Illinois Urbana-Champaign), Kristen L. Meerbrey(Baylor College of Medicine), Kristopher T. Kahle(Broad Institute), Chad A. Shaw(Baylor College of Medicine), Susan G. Hilsenbeck(Baylor College of Medicine), Bing Yu(Center for Cancer Research), Anthony C. Liang(Brigham and Women's Hospital), Ronald J. Bernardi(Baylor College of Medicine), Earlene M. Schmitt(Baylor College of Medicine), Samuel O. Skinner(University of Illinois Urbana-Champaign), Peng Yu(Nanchang University), Michael R. Schlabach(Q Therapeutics (United States)), Tiffany Hsu(Baylor College of Medicine)
Cited by 440
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k